Mazelsky Jonathan Jay's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Nov 9, 2022
- Accession no.
- 0001567619-22-019388
- Filed
- Nov 9, 2022
- Trade date
- Nov 7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.06M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazelsky Jonathan JayCIK 0001556270 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | Common Stock | MOption exerciseAcquired | +24,002 | $52.00 | +$1,248,104 | 75,536.64 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −900 | $378.60F2 | −$340,740 | 74,636.64 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −2,000 | $379.50F3 | −$759,000 | 72,636.64 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −500 | $380.85F4 | −$190,425 | 72,136.64 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −3,704 | $382.81F5 | −$1,417,928.24 | 68,432.64 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −2,716 | $383.29F6 | −$1,041,015.64 | 65,716.64 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −3,018 | $384.47F7 | −$1,160,330.46 | 62,698.64 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −392 | $385.01F8 | −$150,923.92 | 62,306.64 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | Common Stock | MOption exerciseDisposed | −24,002 | –F10 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of the shares sold ranging from a low of $377.99 to a high of $378.95 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of the shares sold ranging from a low of $379.10 to a high of $380.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold ranging from a low of $380.68 to a high of $381.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of the shares sold ranging from a low of $381.94 to a high of $382.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of the shares sold ranging from a low of $382.95 to a high of $383.95 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average price of the shares sold ranging from a low of $383.97 to a high of $384.935 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents the weighted average price of the shares sold ranging from a low of $384.98 to a high of $385.16 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Not applicable.
Referenced by the price of 1 transaction in Table II.